Secondary progressive multiple sclerosis (SPMS) is the second most common form of
multiple sclerosis (MS). One in two relapse remitting multiple sclerosis (RRMS) patients will …

MRI studies have provided valuable insights into the structure and function of neural
networks, particularly in health and in classical neurodegenerative conditions such as …

Importance To our knowledge, the Oral Ponesimod Versus Teriflunomide In Relapsing
Multiple Sclerosis (OPTIMUM) trial is the first phase 3 study comparing 2 oral disease …

Following an acute COVID-19 infection, a large number of patients experience persisting
symptoms for more than four weeks, a condition now classified as Long-COVID syndrome …

Fatigue is the most commonly reported symptom in patients with multiple sclerosis (MS). It is
a worrisome, frequent, and debilitating manifestation that could occur at any time during the …

Background Multiple sclerosis (MS) is an inflammatory disease associated with adverse
effects: including depression, anxiety, fatigue, which may affect physical activity and the …

Multiple sclerosis (MS) is an autoimmune neurodegenerative disease characterized by
demyelination of the central nervous system (CNS). The exact cause of MS is still unknown; …

Cognitive fatigue is one of the most frequent symptoms in multiple sclerosis (MS), associated
with significant impairment in daily functioning and quality of life. Despite its clinical …

Fatigue is one of the most debilitating symptoms in patients with multiple sclerosis (MS).
Despite its clinical significance, the aetiology and pathophysiology of MS-related fatigue are …

Fatigue is one of the most common and debilitating symptoms affecting patients with multiple
sclerosis (MS). Sustained cognitive effort induces cognitive fatigue, operationalized as …